ID

34327

Description

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01170962

Lien

https://clinicaltrials.gov/show/NCT01170962

Mots-clés

Versions (1)
  1. 16/01/2019 16/01/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

16 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatitis C Virus NCT01170962

Anglais

Eligibility Hepatitis C Virus NCT01170962

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects chronically infected with hcv genotype 1
Description

ID.1

Type de données

boolean

non-responder to prior therapy with peginterferon alfa and ribavirin
Description

ID.2

Type de données

boolean

hcv rna viral load of ≥ 100,00 iu/ml
Description

ID.3

Type de données

boolean

results of a liver biopsy ≤ 24 months prior to randomization consistent with chronic hcv infection; for compensated cirrhotics can be any time prior to randomization (compensated cirrhotics will be capped at 10% of randomized study population)
Description

ID.4

Type de données

boolean

ultrasound, ct scan or mri results 12 months prior to randomization that do not demonstrate hepatocellular carcinoma
Description

ID.5

Type de données

boolean

body mass index (bmi) of 18 to 35 kg/m2
Description

ID.6

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
positive for hepatitis b infection (hbsag) or hiv-1/hiv-2 antibody at screening
Description

ID.7

Type de données

boolean

evidence of medical condition associated with chronic liver disease other than hcv
Description

ID.8

Type de données

boolean

evidence of decompensated cirrhosis based on radiologic criteria or biopsy
Description

ID.9

Type de données

boolean

Retour au début de la page

Similar models

Eligibility Hepatitis C Virus NCT01170962

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
subjects chronically infected with hcv genotype 1
boolean
ID.2
Item
non-responder to prior therapy with peginterferon alfa and ribavirin
boolean
ID.3
Item
hcv rna viral load of ≥ 100,00 iu/ml
boolean
ID.4
Item
results of a liver biopsy ≤ 24 months prior to randomization consistent with chronic hcv infection; for compensated cirrhotics can be any time prior to randomization (compensated cirrhotics will be capped at 10% of randomized study population)
boolean
ID.5
Item
ultrasound, ct scan or mri results 12 months prior to randomization that do not demonstrate hepatocellular carcinoma
boolean
ID.6
Item
body mass index (bmi) of 18 to 35 kg/m2
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
positive for hepatitis b infection (hbsag) or hiv-1/hiv-2 antibody at screening
boolean
ID.8
Item
evidence of medical condition associated with chronic liver disease other than hcv
boolean
ID.9
Item
evidence of decompensated cirrhosis based on radiologic criteria or biopsy
boolean
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial